SPY
751.17
QQQ
682.51
+0.21%
BTC/USD
76,916.28
+0.32%
DIA
516.86
−0.48%
GLD
357.82
−1.06%
TLT
81.67
−0.07%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Evolus Inc
EOLS
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$7.16
-0.19
-2.59%
Last update: Nov 2, 4:00 PM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 earnings tomorrow on Wed Nov 4th after the market close
Conference Call:
Conference call scheduled tomorrow at 4:30 PM
Click to view the webcast
Evolus Financials
Evolus (EOLS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Evolus Q2 EPS $(0.12), Sales $84.084M Beat $81.603M Estimate
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 0 percent. This is a 47.83 percent increase over losses of $(0.23) per share from the same
Benzinga Newsdesk
PRO
Evolus Raises FY2026 Sales Guidance from $327.000M-$337.000M to $330.000M-$337.000M vs $330.445M Est
Evolus (NASDAQ:EOLS) raises FY2026 sales outlook from $327.000 million-$337.000 million to $330.000 million-$337.000 million vs $330.445 million estimate.
Benzinga Newsdesk
PRO
Evolus Affirms FY2026 Sales Guidance of $327.000M-$337.000M vs $330.020M Est
Evolus (NASDAQ:EOLS) affirms FY2026 sales outlook from $327.000 million-$337.000 million to $327.000 million-$337.000 million vs $330.020 million estimate.
Benzinga Newsdesk
PRO
Evolus Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $73.137M Beat $72.288M Estimate
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 6.67 percent decrease over losses of $(0.15) per share from the same
Benzinga Newsdesk
Earnings Scheduled For May 4, 2026
Benzinga Insights
Evolus Q4 Earnings Summary & Key Takeaways
Benzinga Insights
